Patient first to take part in trial of new treatment for rare inherited disease
Researchers have recruited the first child into a new study, which aims to evaluate the clinical effectiveness of a treatment developed in Manchester.
Read moreResearchers have recruited the first child into a new study, which aims to evaluate the clinical effectiveness of a treatment developed in Manchester.
Read moreResearchers have recruited the first child into a new study, which aims to evaluate the clinical effectiveness of a treatment developed in Manchester.
Read moreFour year old Joe Hiller, who has a rare inherited disease, has become the first person in the world to participate in a new trial which could alter the lives of fellow sufferers.
Read moreDavid Ray, Professor of Medicine and Endocrinology and Consultant at Manchester Royal Infirmary, was one of a number of researchers feature in a BBC special about the circadian rhythm.
Read moreThe first and only treatment designed for children and adults with the rare genetic condition, Morquio A syndrome, has now been approved for use in the European Union.
Read more